GPX8 and colitis: Treatment with a caspase‐4/11 inhibitor, VX‐765, or a strong antioxidant, N‐acetylcysteine, suppresses caspase‐4/11‐dependent inflammasome activation and reduces DSS‐induced colitis in GPx8−/− mice